EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 3.0

Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial

Charlotte Sandau iD, Ejvind Frausing Hansen iD, Thomas Jørgen Ringbæk iD, Thomas Kallemose iD, Dorthe Gaby Bove, Ingrid Poulsen, Vibeke Nørholm iD, Lars Pedersen iD, Jens Ulrik Stæhr Jensen iD, Charlotte Suppli Ulrik iD

International Journal of Chronic Obstructive Pulmonary Disease · 2023

DOI: 10.2147/copd.s397782 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2023. Verfasst von Charlotte Sandau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Endocrinology, Pulmonary Section, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Devices for Automated Oxygen Administration (AOA) have been developed to optimize the therapeutic benefit of oxygen supplementation. We aimed to investigate the effect of AOA on multidimensional aspects of dyspnea and as-needed consumption of opioids and benzodiazepines, as opposed to conventional oxygen therapy, in hospitalized patients with Acute Exacerbation of COPD (AECOPD). Method and Patients: A multicenter randomized controlled trial across five respiratory wards in the Capital Region of Denmark. Patients admitted with AECOPD (n=157) were allocated 1:1 to either AOA (O2matic Ltd), a closed loop device automatically delivering oxygen according to the patient's peripheral oxygen saturation (SpO2), or conventional nurse-administered oxygen therapy. Oxygen flows and SpO2 levels were measured by the O2matic device in both groups, while dyspnea, anxiety, depression, and COPD symptoms were accessed by Patient Reported Outcomes.

Results

Of the 157 randomized patients, 127 had complete data for the intervention. The AOA reduced patients' perception of overall unpleasantness significantly on the Multidimensional Dyspnea Profile (MDP) with a difference in medians of -3 (p=0.003) between the intervention group (n=64) and the control group (n=63). The AOA also provided a significant between group difference in all single items within the sensory domain of the MDP (all p-values≤0.05) as well as in the Visual Analogue Scale - Dyspnea (VAS-D) within the past three days (p=0.013). All between group differences exceeded the Minimal Clinical Important Difference of the MDP and VAS-D, respectively. AOA did not seem to have an impact on the emotional response domain of the MDP, the COPD Assessment Test, the Hospital Anxiety and Depression Scale, or use of as-needed opioids and/or benzodiazepines (all p-values>0.05).

Conclusion

AOA reduces both breathing discomfort and physical perception of dyspnea in patients admitted with AECOPD but did not seem to impact the emotional status or other COPD symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHumansOxygen Inhalation TherapyDyspneaHospitalizationOxygen

Stichwörter der Autor:innen

COPDadmissionautomated oxygen therapydyspneahospitalmultidimensional dyspnea profileoxygentherapy

Substanzen

Oxygen

Autor:innen und Institutionen

  • Department of Respiratory Medicine and Endocrinology, Pulmonary Section, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
  • Allergy and Lung Clinic, Elsinore, Denmark.
  • Department of Clinical Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
  • University College Absalon, Centre for Nursing, Roskilde, Denmark.
  • Research Unit Nursing and Health Care, Aarhus University, Aarhus, Denmark.
  • Department of Respiratory Medicine and Infectious Diseases, Copenhagen University Bispebjerg Hospital, Copenhagen, Denmark.

ORCID-Profile: Charlotte Sandau, Ejvind Frausing Hansen, Thomas Jørgen Ringbæk, Thomas Kallemose, Vibeke Nørholm, Lars Pedersen, Jens Ulrik Stæhr Jensen, Charlotte Suppli Ulrik

Zitieren

APA

Sandau, C., Hansen, E. F., Ringbæk, T. J., Kallemose, T., Bove, D. G., Poulsen, I., Nørholm, V., Pedersen, L., Jensen, J. U. S., & Ulrik, C. S. (2023). Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s397782

Vancouver

Sandau C, Hansen EF, Ringbæk TJ, Kallemose T, Bove DG, Poulsen I, et al. Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease. 2023. doi:10.2147/copd.s397782

BibTeX
@article{Sandau2023,
  author = {Sandau, Charlotte and Hansen, Ejvind Frausing and Ringbæk, Thomas Jørgen and Kallemose, Thomas and Bove, Dorthe Gaby and Poulsen, Ingrid and Nørholm, Vibeke and Pedersen, Lars and Jensen, Jens Ulrik Stæhr and Ulrik, Charlotte Suppli},
  title = {Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2023},
  doi = {10.2147/copd.s397782}
}
Kostenlos starten →